Ford to fix coolant leaks in vehicles recalled for fire risk
Ford says it will repair any coolant leaks that might be found in more than 200,000 recalled vehicles that are at risk of catching fire.
Flu strain is severe this year, get the vaccine: Dr. Siegel
Dr. Marc Siegel discusses concerns over the effectiveness of the current flu vaccine.
5 things small business owners should know or do in 2018
Small business owners have entered 2018 with many questions about how big their tax bills will be, but they're also optimistic about profiting from a strong economy.
Pfizer, Sangamo partner to develop gene therapy for ALS
Sangamo Therapeutics Inc and Pfizer Inc said on Wednesday they would work together to develop a gene therapy to treat ALS, a disease that affects nerve cells in the brain and the spinal cord.
Pershing Square, Valeant to appear in court on insider trading suit settlement
A U.S. court on Tuesday asked Valeant Pharmaceuticals International and activist investor Bill Ackman's Pershing Square to appear for a hearing to discuss the proposed settlement in an insider trading lawsuit.
Strong factory data, Wall St gains boost Asian share prices
U.S. stocks are starting the new year higher thanks in part to gains in technology companies and retailers, some of the market's biggest gainers from 2017.
Big pharma accused of price gouging life-saving drugs
Last January, shortly before his presidency began, Donald Trump promised to end big pharmaceutical companies’ stranglehold on drug prices and the healthcare industry; but more than a year later, drug companies continue to face almost no competition while steadily raising their prices.
U.S. medical device tax back in effect after two-year pause
A 2.3 percent tax on the sale of medical devices went back into effect on Monday after a two-year suspension, despite opposition by U.S. lawmakers and the medical manufacturing industry.
Tax on medical devices to resume after 2-year suspension
While much of corporate America will enjoy a tax cut in 2018, one industry is getting a tax increase.
Health care: Where entitlement reform, infrastructure meet, Blackburn says
After passing a sweeping tax overall earlier this month, President Donald Trump and fellow Republicans have their sights set on entitlement reform and fixing America’s infrastructure.
US investigating Ford transmission recall involving F-150
Federal safety officials are investigating whether a Ford Motor Co. transmission recall should be widened to fix more than a million additional vehicles.
Goldman Sachs and Hess slide while PepsiCo and TiVo rise
Stocks that moved substantially or traded heavily Friday: Adtran Inc., down $2.90 to $19.35 The networking equipment maker gave weak revenue forecasts because a major customer is spending less.
Premature balding a sign of early heart disease risks?
Hairline and heart disease
Martin Shkreli's ex-lawyer found guilty of financial fraud
A lawyer accused of helping pharmaceutical entrepreneur Martin Shkreli (SHKREL'-ee) cover up a financial fraud has been convicted in New York.
Trump administration looking to lower price of health care plans next year
President Donald Trump is planning to sign a new executive order to make cheaper health care plans more accessible to consumers, a White House official confirmed to Fox News on Wednesday.
Factor in safety before choosing a new dresser or TV
Thinking about getting a new flat-screen TV for the holidays, or a dresser for the baby's room?
Edmunds Sizes Up New Car-Safety Technology
We are in a new era of car safety: The focus has shifted from reducing death and injury in a vehicle collision to preventing a crash from happening in the first place.
Asian stocks mixed in quiet holiday trading
U.S. stocks edged mostly lower in light trading early Tuesday as markets reopened following the Christmas holiday.
Kohl's and Sucampo climb while Apple and Qorvo stumble
Stocks that moved substantially or traded heavily Tuesday: Sucampo Pharmaceuticals Inc. (SCMP) The constipation and irritable bowel syndrome drugmaker agreed to be bought by Mallinckrodt for $18 a share, or $839 million.
Does the lack of generics lead to price gouging by pharmaceutical companies?
Efforts to rein in drug prices














